Verónica Aramendia-Vidaurreta1,2, Sergio M. Solís-Barquero1,2, Ana Ezponda1,2, Marta Vidorreta3, Rebeca Echeverria-Chasco1,2, Marina Pascual4, Gorka Bastarrika1,2, and María A. Fernández-Seara1,2
1Radiology, Clínica Universidad de Navarra, Pamplona, Spain, 2IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain, 3Siemens Healthineers, Madrid, Spain, 4Cardiology, Clínica Universidad de Navarra, Pamplona, Spain
Synopsis
Keywords: Arterial spin labelling, Perfusion
Splenic switch-off, defined as the stress
to rest splenic blood flow (SBF) attenuation in response to adenosine, is an
indicator of stress adequacy. This study aims to explore the ability of
pseudo-continuous arterial spin labeling (PCASL) to identify splenic switch-off
in patients with suspected CAD. In healthy subjects, multi-delay PCASL data
were acquired to quantify SBF and determine the adequate postlabeling delay. In
patients, single-delay PCASL and first-pass perfusion images were acquired
under rest and adenosine conditions. This study could demonstrate the
feasibility of PCASL to identify splenic switch-off during adenosine perfusion
MRI.
INTRODUCTION
In patients
with suspected coronary artery disease (CAD), myocardial perfusion is measured
under rest and pharmacologically induced stress to identify potential areas of
ischemia, but inadequate stress levels can cause false negative findings in the
MRI perfusion scan[1].
Splenic switch-off has been proposed as an indicator of stress adequacy and it
has been successfully assessed in first pass images during study interpretation[2]–[6]. Non
contrast imaging techniques such as arterial spin labeling are beneficial for
the real time evaluation of splenic switch off. The main goal of this study is
to evaluate the potential of pseudo-continuous ASL (PCASL) to identify splenic
switch-off in rest-stress adenosine perfusion studies and to validate the
technique against first-pass imaging in patients with suspected CAD.METHODS
Five
healthy volunteers (age 24.8 ± 3.8 years) and 32 patients (age 66.4 ± 8.2
years) were recruited for the study. Data acquisition was performed in a 1.5 T
Aera scanner. In healthy subjects, a multi-delay PCASL sequence was acquired
with six different post-labeling delays (PLDs:500, 700, 1000, 1200, 1500, and
2000 ms), labeling duration of 1600 ms, 90% background suppression, and spin
echo–echo planar imaging readout. 50 label-control images per PLD and a
proton-density image were acquired.
In
patients, a single-delay PCASL sequence was acquired with the optimal PLD (1200
ms) obtained from the study with healthy subjects. A maximum of 30
label-control images and a proton density image were acquired under rest and
stress conditions. These sequences were added to the clinical protocol (Figure-1)
prior to the acquisition of first-pass images to avoid the T1 reduction effects
by gadolinium. During stress, the PCASL sequence was initiated with adenosine
infusion and stopped before the first-pass sequence. The
perfusion protocol included ECG-triggered stress-rest first-pass short axis
images of the heart during free breathing. The
adenosine infusion was initiated using the standard dosage (140 μg/kg/min) and
increased to 180 μg/kg/min whenever there was not a 10-bpm increase in patient
heart rate during the subsequent 3–4 minutes.
Splenic
blood flow perfusion data were quantified using equation presented in Figure-2.
Stress-to-rest SBF ratios were computed to evaluate splenic switch-off. In
first-pass data, semiquantitative perfusion quantification was performed in
both myocardial and splenic tissue in one short-axis slice where the spleen
could be observed. Three
observers visually evaluated rest and stress perfusion images obtained with
PCASL and First-Pass and classified patients in “switch-off” or “failed
switch-off” categories. Patients with a visual attenuation of splenic perfusion
were classified as having experienced switch-off.
Statistical
tests: Wilcoxon signed-rank, kappa, percentage agreement, Generalized Linear Mixed Model, receiver
operating characteristic, area-under-the-curve (AUC) and confusion matrix.RESULTS AND DISCUSSION
Multi-delay
PCASL was feasible in healthy subjects, with measured splenic perfusion being
in agreement with previously reported values[7]. Multi-delay
PCASL yielded perfusion images for each PLD (Figure-3a), with a group mean
splenic perfusion signal of 1.45% for the 500 msec PLD, which increased to a
maximum value of 1.59% for the 1000 msec PLD and decreased for longer PLDs (Figure-3b). A PLD of 1200 msec was selected for the
single-delay analysis (to ensure PLD > ATT and thus complete delivery of
labeled blood to tissue), which yielded SBF values of 139.7 mL/100 g/min (SD:
37.5, range 94.4– 192.9 mL/100 g/min). No significant differences were observed
between SBF values derived from single and multi-delay data (P = 0.65) (Figure-3c).
Adequate
SBF maps were obtained for 32 patients. Group
mean SBF values were 105.3 mL/100 g/min (SD: 56.8 mL/100 g/min) at rest and
57.9 mL/100 g/min (SD: 54.2 mL/100 g/min) under stress, a difference that was
statistically significant. Figure 4 shows quantitative perfusion maps for two
representative patients with and without switch-off obtained with PCASL during
rest and stress. No significant differences (P = 0.58) were found in the splenic ratios measured by first-pass and PCASL, but these ratios were significantly lower than those obtained in the myocardium.
Splenic switch-off
occurred in 84.4% of patients according to the first-pass visual assessment
performed by the radiologists (κ = 0.916). Visual assessment of splenic
switch-off from PCASL data showed a strong interobserver agreement (κ = 0.878). Intertechnique agreement was fair (κ = 0.23 and 78.7% percentage agreement). The results of the GLMM estimation showed that the difference between techniques was nonsignificant (estimate = 1.3261, SE = 0.9800, z-value = 1.253, P value = 0.176), indicating that the two techniques may be used interchangeably. Stress-to-rest
splenic ratios measured with both PCASL and first-pass were significantly lower
than those obtained in the myocardium. This supports the idea that splenic
perfusion is attenuated with adenosine stress in comparison to myocardial
perfusion.
Figure 5 shows ROC curves for the
discrimination between splenic switch-off and failed switch-off stress-to-rest
perfusion ratios. First-pass ROC analysis yielded a cut-off of 0.74. Classification
results using this threshold were in full accordance with those obtained by
visual assessment (sensitivity =100%, specificity = 100%, AUC = 100%). For
PCASL, the optimal a cut-off was 0.96 (sensitivity = 80%, specificity = 100%,
AUC = 85.2%).CONCLUSION
This study could demonstrate the
feasibility of using PCASL to identify splenic switch-off during adenosine
stress cardiac MRI in patients with suspected CAD.
Acknowledgements
Grant Support: Sergio M. Solís-Barquero received PhD grant support from Fundación Carolina and Universidad de Costa Rica.
Spanish Ministry of Science and Innovation (grant: PI21/00578).
References
[1] S.
Plein et al., “Associated factors for a false negative cardiovascular
magnetic resonance perfusion study: a CE-MARC substudy,” J. Cardiovasc.
Magn. Reson., vol. 15, no. S1, p. P214, 2013, doi:
10.1186/1532-429x-15-s1-p214.
[2] C.
Manisty et al., “Splenic Switch-off: A Tool to Assess Stress Adequacy in
Adenosine Perfusion Cardiac MR Imaging.,” Radiology, vol. 000, no. 0, p.
142059, 2015, doi: 10.1148/radiol.2015142059.
[3] D.
Patriki et al., “Splenic switch-off as a predictor for coronary
adenosine response: validation against 13N-ammonia during co-injection
myocardial perfusion imaging on a hybrid PET/CMR scanner,” J.
Cardiovasc. Magn. Reson., vol. 23, no. 1, pp. 1–7, 2021, doi:
10.1186/s12968-020-00696-y.
[4] A.
Bakula et al., “Splenic switch-off as a novel marker for adenosine
response in nitrogen-13 ammonia PET myocardial perfusion imaging:
Cross-validation against CMR using a hybrid PET/MR device,” J. Nucl.
Cardiol., vol. 29, no. 3, pp. 1205–1214, Jun. 2022, doi:
10.1007/s12350-020-02448-y.
[5] A.
Hosking et al., “Evaluation of splenic switch off in a tertiary imaging
centre: Validation and assessment of utility,” Eur. Heart J. Cardiovasc.
Imaging, vol. 18, no. 11, pp. 1216–1221, 2017, doi: 10.1093/ehjci/jew205.
[6] S.
Giusca et al., “Splenic Switch-Off for Determining the Optimal Dosage
for Adenosine Stress Cardiac MR in Terms of Stress Effectiveness and Patient
Safety,” J. Magn. Reson. Imaging, vol. 52, no. 6, pp. 1732–1742, 2020,
doi: 10.1002/jmri.27248.
[7] C.
R. Bradley et al., “Multi-organ assessment of compensated cirrhosis
patients using quantitative magnetic resonance imaging,” J. Hepatol.,
vol. 69, no. 5, pp. 1015–1024, 2018, doi: 10.1016/j.jhep.2018.05.037.